BioCentury
ARTICLE | Clinical News

PLX cells: Phase I/II started

December 3, 2012 8:00 AM UTC

Pluristem began a double-blind, placebo-controlled, German Phase I/II trial to evaluate 2 doses of intramuscular injections of PLX cells into the lacerated gluteal muscle before suturing during hip re...